Moleculera Labs announces rebrand to Moleculera Biosciences as company expands into new sectors
Rebrand aligns with precision medicine messaging for growth and expansion into additional immune-mediated disorder markets OKLAHOMA CITY, OK, USA, July 30, 2024 /EINPresswire.com/ -- Moleculera Labs, a precision medicine company focused on uncovering the immune-mediated roots of chronic central nervous system (CNS) and cardiovascular disorders, is pleased to announce it has rebranded to Moleculera Biosciences to more accurately reflect the company’s expanded scope of research and product offerings. …